Skip to main content
INNOVA CAPTAB LIMITED logo

INNOVA CAPTAB LIMITED — Investor Relations & Filings

Ticker · INNOVACAP ISIN · INE0DUT01020 LEI · 549300SNL5HFUHE66804 BSE.NS Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2024-08-23 AGM Information
Country IN India
Listing BSE.NS INNOVACAP

About INNOVA CAPTAB LIMITED

https://www.innovacaptab.com

Innova Captab Limited is an integrated pharmaceutical company focused on the research, development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company operates primarily as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services to leading domestic and international pharmaceutical brands. Its product portfolio includes diverse dosage forms such as tablets, capsules, dry syrups, ointments, and injections across multiple therapeutic areas, including anti-infectives, analgesics, and gastrointestinal treatments. Innova Captab maintains a strong emphasis on R&D and quality control, operating advanced manufacturing facilities that adhere to global regulatory standards. In addition to its CDMO business, the company manages a domestic branded generics division and an international export business, catering to a global clientele with a focus on high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is an intimation letter dated August 23, 2024, from Innova Captab Limited addressed to stock exchanges (BSE and NSE). It announces the publication of a newspaper advertisement regarding the 20th Annual General Meeting (AGM) to be held on September 18, 2024, through video conferencing. The letter references compliance with SEBI Listing Regulations and MCA circulars related to AGMs. The content is primarily about notifying the stock exchanges of the advertisement for the AGM and the meeting details, not the AGM materials themselves or the voting results. The document length is about 15,000 characters, but the content is an announcement of the AGM advertisement, not the AGM presentation or minutes. Therefore, it fits best under the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related announcements. However, since this is specifically about the advertisement/intimation of the AGM and not the AGM materials themselves, it is more precisely an AGM Information filing rather than a report publication or voting results announcement.
2024-08-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call held by Innova Captab Limited on August 12, 2024, discussing the financial and operational performance for Q1 FY25. It includes management commentary, financial highlights such as revenue, EBITDA, and PAT, business segment performance, recent developments, and a Q&A session with analysts. The presence of a full transcript of the earnings call, including management remarks and Q&A, clearly identifies this as a Call Transcript (CT). The document length (15,000 characters) and content confirm it is not a brief announcement or a report publication notice but the full transcript itself.
2024-08-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to stock exchanges (BSE and NSE) regarding the availability of the audio recording of the earnings call for the quarter ended June 30, 2024. It references Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements, which governs disclosures related to material events. The document does not contain financial data or detailed financial results but provides a link to the audio recording of the earnings call. The document length is short (1758 characters), and it serves as a notification rather than the actual earnings release or transcript. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about the earnings call audio availability, not the earnings release itself or the transcript.
2024-08-12 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) dated August 10, 2024, informing about the approval of the unaudited standalone and consolidated financial results for the quarter ended June 30, 2024. It includes a newspaper advertisement extract with summarized financial data for the quarter and year ended March 31, 2024. The document references Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates disclosure of financial results through newspaper advertisements. The document is not the full financial report but an announcement of the financial results publication via newspaper advertisement. The length is about 5206 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an official regulatory announcement of financial results, not the full quarterly report itself.
2024-08-10 English
Updates
Regulatory Filings
2024-08-09 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is an investor presentation dated August 9, 2024, for the quarter ended June 30, 2024 (Q1 FY25). It includes detailed financial highlights, MD's commentary, quarterly consolidated profit and loss statements, corporate snapshot, business overview, and strategic outlook. The document explicitly states it is an "Investor Presentation" and is provided pursuant to a regulatory requirement to inform about an earnings call. It contains substantive financial data and analysis, including revenue, EBITDA, PAT, margins, and segment information. It is not a brief announcement or a certification letter, nor is it a full annual or interim report. The presence of detailed financial and operational data, forward-looking statements, and strategic commentary aligns with the definition of an Investor Presentation (IP).
2024-08-09 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.